Early CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials Meeting Abstract
| Authors: | Lorente, D.; Olmos, D.; Mateo, J.; Bianchini, D.; Seed, G.; Flohr, P.; Crespo, M.; Figueiredo, I.; Miranda, S.; Baeten, K.; Pitfield, T.; Molina, A.; Kheoh, T.; McCormack, R. T.; Scher, H. I.; de Bono, J. S. |
| Abstract Title: | Early CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901056 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.5014 |
| Notes: | Meeting Abstract: 5014 -- Source: Wos |
